Armata Pharmaceuticals, Inc. Common Stock — 분기별 재무제표 (NYSE:ARMP) | MetaTrader

전체 차트 열기 Full chart

뉴스

H.C. Wainwright, Armata Pharmaceuticals 목표가 $15로 하향

H.C. Wainwright lowers Armata Pharmaceuticals stock price target to $15

Armata Pharmaceuticals, FDA 지정에 주가 상승

Armata Pharmaceuticals stock gains on FDA designation

Armata, FDA로부터 QIDP 지위 획득

FDA grants QIDP status to Armata’s staph infection treatment

Innoviva stock gains BTIG coverage with buy rating on royalty windfall

Armata, S. aureus 치료제 3상 임상 진행

Armata to advance bacteriophage therapy to phase 3 for S. aureus

존스 트레이딩, Armata Pharmaceuticals에 ’매수’ 등급 제시

Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating

Armata Pharma Q3 실적, 수익 에상치보다 저조